2020
DOI: 10.1177/1934578x20916328
|View full text |Cite
|
Sign up to set email alerts
|

Prunetin Protects Against Dexamethasone-Induced Pancreatic Β-Cell Apoptosis via Modulation of p53 Signaling Pathway

Abstract: Long-term administration of dexamethasone results in insulin resistance and pancreatic β-cell apoptosis. Prunetin (an O-methylated isoflavone, a type of flavonoid) is demonstrated to protect diabetes, but the molecular mechanism of this protection is still unclear. This study thus aims to investigate how prunetin protects against dexamethasone-induced pancreatic β-cell apoptosis. Rat insulinoma (INS-1) cells were cultured in medium with or without dexamethasone in the presence or absence of prunetin or pifithr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…A recent study of prunetionoside identified the essential targets on gastric cancer cells to be HSP90, CDK2, and MMP1 with their binding potential confirmed through molecular docking analysis (Vetrivel et al 2021). Kooptiwut et al (2020) reported that prunetin (aglycan form) protected dexamethasone-induced apoptosis of pancreatic cells in rat insulinoma (INS-1) cells through the p53 signaling pathway. Treatment with dexamethasone combined with prunetin considerably reduced Bax and Rb protein expressions while it increased the Bcl 2 protein expression (Kooptiwut et al 2020).…”
Section: Prunetionosidementioning
confidence: 99%
See 1 more Smart Citation
“…A recent study of prunetionoside identified the essential targets on gastric cancer cells to be HSP90, CDK2, and MMP1 with their binding potential confirmed through molecular docking analysis (Vetrivel et al 2021). Kooptiwut et al (2020) reported that prunetin (aglycan form) protected dexamethasone-induced apoptosis of pancreatic cells in rat insulinoma (INS-1) cells through the p53 signaling pathway. Treatment with dexamethasone combined with prunetin considerably reduced Bax and Rb protein expressions while it increased the Bcl 2 protein expression (Kooptiwut et al 2020).…”
Section: Prunetionosidementioning
confidence: 99%
“…Kooptiwut et al (2020) reported that prunetin (aglycan form) protected dexamethasone-induced apoptosis of pancreatic cells in rat insulinoma (INS-1) cells through the p53 signaling pathway. Treatment with dexamethasone combined with prunetin considerably reduced Bax and Rb protein expressions while it increased the Bcl 2 protein expression (Kooptiwut et al 2020). Prunetin induced necroptotic cell death in AGS cells via RIPK3 provocation which leads to MLKL-phosphorylation and ROS generation (Vetrivel et al 2020).…”
Section: Prunetionosidementioning
confidence: 99%
“…PRU is widely known for its ability to inhibit the action of growth factors in vitro , as a strong tyrosine kinase inhibitor. Although PRU was reported to have a protective effect against dexamethasone-induced pancreatic beta cell apoptosis ( Kooptiwut et al ., 2020 ), effects of PRU on STZ-induced DN still remain uncertain. Insulin therapy is one of the therapeutic modalities used to treat diabetes.…”
Section: Introductionmentioning
confidence: 99%